16 articles
Sisen Technology, founded in December 2025 by Tsinghua and ETH Zurich alumni, raised tens of millions of yuan in seed funding co-led by Inno Angel Fund and Tsinghua Alumni Seed Fund, targeting glioblastoma blood-brain-barrier opening as its first indication.
Guangzhou and Shenzhen will split the work of building China's most ambitious provincial brain-computer interface industry under a 'Dual-Core' Action Plan released 24 June 2026: 10 billion yuan core industry, 100 new enterprises, 200 BCI hospital wards by 2030.
Vice Premier Liu Guozhong inspected the Brain-Computer Interface Research Institute at Nanjing University on 22-23 June 2026, naming BCI a 'key area of international industrial competition' per Xinhua and NJU.
Neuracle, maker of the world's first approved invasive BCI, had a RMB 2.5B Shanghai STAR Market IPO prospectus accepted on 11 June 2026, opening a two-horse race with BrainCo for first publicly listed pure-play BCI.
Between 1 May and 19 June 2026, three operational state-backed brain-computer interface moves landed across China and South Korea. China State Council Order No. 818 took effect on 1 May 2026, opening a parallel commercial pathway for advanced biomedical technologies that names BCI explicitly. Tianjin formally inaugurated a dedicated BCI industrial cluster with 100 million yuan in annual funding on 29 May 2026. South Korea launched its first national BCI industry association in Seoul on 16 June 2026, anchored to the K-Moonshot strategic R&D mission. Three dated, named, primary-sourced moves in eight weeks across two jurisdictions.
Per China Daily, the city of Tianjin formally inaugurated a dedicated BCI industrial cluster at the 2026 World Intelligence Expo, with 100 million yuan (about $14.8M) annual funding committed, 22 BCI companies already incubated in the zone, and a target of 50 enterprises by 2027.
Hundreds of specialists watched Beijing Tiantan Hospital implant Beinao-1, China's 128-channel semi-invasive brain-computer interface, in a young man paralysed in a scooter accident — part of a clinical ramp that is closing on Neuralink's implant count at roughly 1% of its price.
BrainCo's new Revo 3 dexterous hand applies neural decoding and tactile sensing from prosthetic limbs to humanoid robotics, backed by a US$286 million funding round.
Brain-computer interfaces appeared in China's government work report for the first time during the 2026 'two sessions,' placing the technology alongside quantum computing and 6G as a national strategic priority.
Five patients now carry the coin-sized wireless implant that sits on the brain's protective membrane rather than penetrating tissue, with one ALS patient decoding nearly 100 Chinese words.
The two-month-old startup founded by Shanda billionaire Tianqiao Chen and former NeuroXess founder Phoenix Peng secures the largest early-stage BCI funding in China, betting that focused ultrasound can reach deeper brain circuits than any implant.
The Chinese neural interface company begins construction of the country's first dedicated manufacturing facility for implantable brain-computer interfaces in Nanchang, signaling a shift from lab to production line.
Seven Chinese government bodies have released guidelines establishing a roadmap for brain-computer interface development, with BCI procedures now receiving medical insurance reimbursement in parts of the country.
A Chinese company is developing non-invasive ultrasound brain-computer interfaces to treat chronic pain, intensifying competition in alternatives to surgical neural implants.
Chinese BCI company NeuroXess has surpassed human trial milestones, positioning itself as a direct competitor to Neuralink in the global neural interface market.
Brazilian neuroscientist Miguel Nicolelis leads research with Chinese collaborators demonstrating that brain-computer interface technology can trigger neural reorganization and restore movement in paralyzed patients.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. One-click unsubscribe. We respect your privacy.